Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Inoperable Hepatocellular Carcinoma
DRKS00000012Phase 3Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Sep 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in hepatocellular carcinoma (HCC), sponsored by Universitätsklinikum Freiburg. Started Sep 2008; status: completed.
02
Drugs
octreotide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on DRKS00000012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000012.